Posterior Predictive Design for Phase I Clinical Trials

DOI10.1080/01621459.2025.2484044MaRDI QIDQ6878035zbMATH OpenFDO

Authors Shouhao Zhou

Publication date 7 January 2026

Published in Journal of the American Statistical Association (Search for Journal in Brave)

Copyright license Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Full work available at URL https://doi.org/10.1080/01621459.2025.2484044

Mathematics Subject Classification ID

Statistics (62-XX)

Cites work

• A STATISTICAL PARADOX
• Bayes Factors
• Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
• Bayesian optimal interval designs for phase I clinical trials
• Coherence principles in dose-finding studies
• Comparative review of novel model-assisted designs for phase I clinical trials
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Dose-finding designs: the role of convergence properties
• scientific article; zbMATH DE number 1522698 (Why is no real title available?)
• scientific article; zbMATH DE number 3390139 (Why is no real title available?)
• Semiparametric Dose Finding Methods
• Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities

This page was built for publication: Posterior Predictive Design for Phase I Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6878035)